Related Experiment Video
Updated: Jun 24, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
[Favorable response of pulmonary rheumatoid nodule to Rituximab]
T Oqueka1, H Schultz, F Moosig
1Klinik für Immunologie und Rheumatologie , Klinikum Bad Bramstedt, Oskar-Alexander-Strasse 26, Bad Bramstedt, Germany. oqueka@klinikumbb.de
Abstract:
Pulmonary rheumatoid nodules can be found in over 4% of patients with rheumatoid arthritis. Diagnostically they have to be differentiated from malignant and infectious processes. The present article describes a case of pulmonary rheumatoid nodule which responded well to Rituximab therapy.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management